Nopphadol Nuntamool

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels

Natchaya Vanwong, Nattawat Ngamsamut, Yaowaluck Hongkaew et al. · Drug Metabolism and Pharmacokinetics · 2016 · 35 citations

Psychiatry, Syndromic Autism, Medicine +8

Pharmacogenomics and Efficacy of Risperidone Long‐Term Treatment in Thai Autistic Children and Adolescents

Nopphadol Nuntamool, Nattawat Ngamsamut, Natchaya Vanwong et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 32 citations · Full text

Pharmacogenetics of Risperidone‐Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder

Chonlaphat Sukasem, Natchaya Vanwong, Pornpen Srisawasdi et al. · Basic & Clinical Pharmacology & Toxicology · 2018 · 32 citations · Full text

Genetics, Human Polymorphism, Genetic Epidemiology +17

Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects

Natchaya Vanwong, Pornpen Srisawasdi, Nattawat Ngamsamut et al. · Frontiers in Pharmacology · 2017 · 27 citations · Full text

<i>CYP2D6</i> Genotype Analysis of a Thai Population: Platform Comparison

Monpat Chamnanphon, Andrea Gaedigk, Natchaya Vanwong et al. · Pharmacogenomics · 2018 · 20 citations